Medical News

RSS

Latest genetic research on ADHD

A special issue of American Journal of Medical Genetics (AJMG): Part B: Neuropsychiatric Genetics presents a comprehensive overview of the latest progress in genetic research of Attention Deficit/Hyperactivity Disorder (ADHD).

7 Jan 2009

Pap test procedure facts

January is Cervical Cancer Awareness Month and The University of Texas M. D. Anderson Cancer Center shares important information about the cervical cancer screening exam, the Pap test.

7 Jan 2009

Restoring trust harder when it is broken early in relationship

In relationships built on trust, a bad first impression can be harder to overcome than a betrayal that occurs after ties are established, a new study suggests.

7 Jan 2009

Researchers measure repulsive Casimir forces

Researchers from Harvard University and the National Institutes of Health (NIH) have measured, for the first time, a repulsive quantum mechanical force that could be harnessed and tailored for a wide range of new nanotechnology applications.

7 Jan 2009

Discovery of target that could ease spinal muscular atrophy symptoms

There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA.

7 Jan 2009

Repeat cesarean deliveries before 39 weeks raises risk of neonatal illness

Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.

7 Jan 2009

United States preterm birth rate continues to rise

New government statistics confirm that the decades-long rise in the United States preterm birth rate continues, putting more infants than ever at increased risk of death and disability.

7 Jan 2009

Osteotech starts trial for DuraTech BioRegeneration Matrix

Osteotech, Inc. announced today that it has initiated a pivotal clinical trial for its DuraTech BioRegeneration Matrix.

7 Jan 2009

Nitric oxide monitoring does not help most children with asthma

The level of nitric oxide (NO) in an asthmatic's exhaled breath can portend worsening asthma symptoms, and may even signify an imminent attack linked to underlying airway inflammation.

7 Jan 2009

Winter babies face socioeconomic disadvantages

Many of us may often feel that we've been born under an unlucky sign.

7 Jan 2009

Metabolic syndrome risk for veterans with post-traumatic stress disorder

Veterans with post-traumatic stress disorder (PTSD) are more likely to have metabolic syndrome than veterans without PTSD.

7 Jan 2009

Scientists visualize the mechanism of synthesizing estrogen

The molecular details of Aromatase, the key enzyme required for the body to make estrogen, are no longer a mystery thanks to the structural biology work done by the Ghosh lab at the Hauptman-Woodward Medical Research Institute (HWI) in Buffalo, New York.

7 Jan 2009

Genomics in China

Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai.

7 Jan 2009

New method for implanting aortic heart valves

An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered to patients at NewYork-Presbyterian Hospital/Columbia University Medical Center.

7 Jan 2009

Health-care providers and patients differ on views of knee replacement

Total knee replacement (TKR) is a common treatment for osteoarthritis, a disease affecting more than 20 million Americans.

7 Jan 2009

GSK completes tender offer for shares of Genelabs Technologies

GlaxoSmithKline plc has announced the successful completion of the tender offer by its wholly-owned subsidiary Gemstone Acquisition Corporation for shares of common stock of Genelabs Technologies, Inc.

7 Jan 2009

Gene marker may improve odds of stem cell therapies for disease

A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Cancer Research and Molecular Medicine report.

7 Jan 2009